Back to article: Targeting the TGFβ pathway in uterine carcinosarcoma


FIGURE 1: Role of TGFβ1 in mediating an aggressive UCS phenotype.(A) Relative mRNA expression of TGFβ1, TGFβ2, TGFβR1, and TGFβR2 in UMMT-ARK1 and CS-99 cells. Data are mean ± SE. (B) 1×104 UMMT-ARK1 and CS-99 cells were grown in 3D culture, once the colonies were visible they were treated as indicated for 48 h and imaged. Representative images are shown. (C) 1×104 UMMT-ARK1 and CS-99 cells were plated in Matrigel, treated with either control vehicle (V), TGFβ1 (5 ng/ml), or GLT (5 µM) + TGFβ1. Colonies were imaged and quantitated using Optronix Gelcount colony counter, % clonal growth compared to vehicle treated control are shown. (D) Representative images of CS-99 cells plated on Oregon Green 488 Gelatin–coated coverslips and treated with 5 ng/ml TGFβ1 for 18 h. The cells were fixed and the cellular F-Actin was stained with Alexa Fluor 555 Phalloidin and mounted in VECTASHIELD mounting medium containing DAPI, the dark areas in the left panels represent FITC-gelatin degradation. (E) Relative fold invasion derived from evaluation of <100 cells as shown in (D). Error bars represent standard deviation. *, P<0.05 was considered significant.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.

Close